Natco Pharma January-March Profit Rises 5% But Misses Estimates; Revenue Up 14%

Natco Pharma Ltd.'s consolidated net profit for the March quarter rose 5.3% on year to ₹4.07 billion, missing analysts’ estimate of ₹4.80 billion. Revenue from operations climbed 14.3% to ₹12.21 billion, while sequentially, net profit tripled and revenue more than doubled.

Other income increased to ₹663 million from ₹420 million a year ago.

Total expenditure, including finance cost, rose to ₹7.81 billion from ₹6.33 billion. Finance cost jumped 64.5% to ₹102 million.
The tax outgo for the quarter was ₹999 million, compared with ₹913 million a year ago.

For the financial year 2024–25, net profit surged 35.8% to ₹18.85 billion, while revenue rose 10.8% to ₹44.3 billion.